Does drug-coated balloon angioplasty reduce target lesion failure risk in patients with de novo lesions on the left anterior descending artery?
Drug-coated balloon angioplasty for de novo LAD lesions reduces stent burden and may lower midterm target lesion failure risk.
A DCB-based treatment approach for left anterior descending revascularization allows a significantly reduced stent burden, thereby potentially limiting target lesion failure risk at midterm follow-up.
Gitto et al. (Tue,) studied this question.